Insights On Enterprise Solutions

  1. New Robot-Compatible Sterile Connectors Enhance Cell Therapy Manufacturing 6/11/2026

    Discover how automating sterile fluid transfers removes human contamination risks, solves operator shortages, and reduces cell therapy manufacturing costs by up to 74%.

  2. QC-Ready Assays By Design 6/11/2026

    Early analytical alignment and standardized assay design reduce variability. Discover an ATP-driven approach that enables reproducible data, smoother tech transfer, and stronger regulatory readiness.

  3. The Hidden Challenges Of Biologics Development 6/11/2026

    Biologics development leaders discuss industry challenges, including innovation pressures, operational complexity, leadership decisions, and maintaining quality and resilience in an evolving landscape.

  4. Efficient Monitoring Of Escherichia Coli Feeding Strategies 6/10/2026

    Consistent, contamination-free sampling is critical for reliable bioprocess data. Automation enables frequent, hands-free collection, improving efficiency and insight while reducing manual workload.

  5. Viral Safety Testing In Biologics: Detecting What Current Methods Miss 6/10/2026

    Biologics face unpredictable risks as complexity grows; evolving testing strategies to broaden detection, address gaps, and strengthen safety confidence without disrupting development or compliance.

  6. SPTFF High Concentration mAb Formulation Case Study 6/10/2026

    Learn how single-pass tangential flow approaches improve efficiency, scalability, and product quality while addressing key development and processing challenges.

  7. How To Maximize Pipeline Value And Enhance eNPV 6/9/2026

    Find out how reducing vendor fragmentation can improve program continuity, minimize delays, and support more predictable development outcomes.

  8. Cracking Complexity: Learnings From 70+ Bispecific Antibody Programs 6/9/2026

    The goal is practical: help development teams make early decisions that balance speed, quality, and risk and support a smoother path to the clinic.

  9. Designing And Selecting Antibody-Oligonucleotide Conjugates 6/9/2026

    View antibody-oligonucleotide conjugate design, highlighting antibody formats, linker strategies, and screening methods to optimize delivery, stability, and gene-targeting therapeutic performance.

  10. AOC GMP Manufacture For A FIH Study 6/9/2026

    See an outline antibody-oligonucleotide conjugate manufacturing: process development, scale-up, GMP production, and analytical controls for efficient early-phase clinical material generation